Wellness Check with the AIPLA Diversity Committee

June 24, 2020 3:00 PM to 4:00 PM

Location

Online

Registration

Fee: FREE

Register Now

As mentioned in AIPLA's June 5th statement, the AIPLA Diversity Committee will be holding a Wellness Check online meeting on Wednesday, June 24th at 3pm EST, where we will have members of our community share thoughts about the recent tragedies of George Floyd, Ahmaud Arbery, Breonna Taylor, and others, and the impact on our community.  There will also be an opportunity for individuals to further share thoughts and participate in the discussion.

Our distinguished speakers include:

  • Mark Charles, Associate General Counsel at Procter & Gamble
  • Mark Whitaker, Past AIPLA President and Partner at Morrison and Foerster
  • Angela Grayson, Vice Chair of AIPLA Diversity and Founder of Precipice IP
  • David D'Zurilla, Principal at Schwegman, Lundberg, Woessner
This is a free program and everyone is welcome. We believe that listening to black voices as they recount their experiences is a small, but meaningful step we should all take to improve our nation and live up to America's ideal of "Equal Justice Under Law".

Add to:

 

 

News

  • AIPLA Comments on Inventorship Guidance for AI-Assisted Inventions

    May 15, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the recently-published Inventorship Guidance for AI-Assisted Inventions.
  • USPTO Building AIPLA Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace

    May 14, 2024

    Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace.
  • AIPLA Files Amicus Brief in REGENXBIO Inc. v. Sarepta Therapeutics, Inc.

    May 14, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state.
  • Supreme Court Affirms Eleventh Circuit’s Ruling in Warner Chappell Music, Inc. v. Sherman Nealy

    May 9, 2024

    On May 9, 2024, the Supreme Court issued a 6-3 decision in Warner Chappell Music, Inc., et al. v. Sherman Nealy, et al., affirming the Eleventh Circuit’s ruling that, provided suit is timely filed under the discovery rule, copyright damages are recoverable for infringements occurring prior to the Copyright Act’s three-year statute of limitations. The majority opinion is consistent with the amicus brief filed by AIPLA on December 1, 2023. To read the opinion of the Court, please click here.
  • AIPLA Comments to Copyright Office on Group Registration of Two-Dimensional Artwork

    April 2, 2024

    Arlington, VA. April 1, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office's Notice of Proposed Rulemaking related to group registration of two-dimensional artwork.